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1. Introduction
Bone is a remarkable tissue as it matches 
mechanical demands and functions with 
a matrix of unique biophysical and bio-
chemical properties.[1,2] The structure 
and architecture of bone is susceptible 
to conditions such as aging, pathologies 
as osteoporosis, but also to physical exer-
cise and nutrition supply.[3,4] Its matrix 
is constantly remodeled to adapt to its 
changing mechanical microenvironment 
and to maintain skeletal functions.[5] 
Cells within bone, therefore, sense 
mechanical inputs to translate them into 
biological responses. Pressure gradients, 
e.g., from mechanical loading and loco-
motion, induce flow of the interstitial 
fluid in the intramedullary space of the 
bone, thereby stimulating osteoblasts.[6,7] 
Jacobs et  al.[8] have shown that immor-
talized human fetal osteoblasts (hFOBs) 
respond to steady and pulsatile unidirec-
tional shear stress but not to oscillatory 
shear stress, indicating an involvement 
of chemotransport facilitated by unidirectional shear stress. 
Osteoblasts are derived from mesenchymal stem cells (MSCs) 
via osteogenic differentiation, a process itself tightly regulated 
by both mechanical forces and biochemical factors, which col-
lectively shape processes such as bone development, homeo-
stasis, and repair.[9]
One of the major instructive factors for bone formation (oste-
ogenesis) is bone morphogenetic proteins (BMPs), secreted 
growth factors belonging to the transforming growth factor-b 
(TGFb  ) superfamily. BMPs signal via binding to heterotetra-
meric receptor complexes consisting of two type I and type II 
serine/threonine kinase receptors (BMPR1 and BMPR2), initi-
ating intracellular SMAD and non-SMAD responses. Activated 
BMP type I receptors phosphorylate SMAD1/5/8, allowing their 
heterotrimeric complex formation with SMAD4 and subsequent 
translocation into the nucleus to regulate transcription of target 
genes, including family members of inhibitor of differentiation 
(ID) genes.[10,11] BMPs are therefore important players of osteo-
genic differentiation, and mutations in BMP pathway compo-
nents can result in severe bone pathologies such as fibrodys-
plasia ossificans progressiva (FOP) or osteoporosis.[12,13] Recom-
binant human BMP-2 and BMP-7 are in clinical use to support 
fracture healing,[14,15] nonetheless their physiological concen-
tration is several magnitudes lower then applied treatment 
Bone is a remarkable dynamic structure, which integrates mechanical and 
biochemical signaling inputs. Interstitial fluid in the intramedullary space 
transmits signals derived from compression-induced fluid shear stress (FSS) 
to stimulate osteoblasts for bone formation. Using a flow system and human 
osteoblasts, this study demonstrates how BMP/TGF-β  signaling integrates 
stimuli derived from FSS and YAP/TAZ and confirms these findings by tran-
scriptome analyses. Here, FSS positively affects the phosphorylation of both 
SMAD1/5 and SMAD2/3, the respective BMP- and TGFβ-R-SMADs. Increase 
in phosphorylated SMAD1/5 levels affects distinct target genes, which are 
susceptible to low levels of phosphorylated SMADs (such as ID1–3) or 
dependent on high levels of phosphorylated SMAD1/5 (NOG, noggin). Thus, 
FSS lowers the threshold for genes dependent on high levels of phosphoryl-
ated SMAD1/5 when less BMP is available. While the impact of FSS on direct 
BMP target genes is independent of YAP/TAZ, FSS acts cooperatively with 
YAP/TAZ on TGF-β  target genes, which are shared by both pathways (such 
as CTGF). As mechanical stimuli are key in bone regeneration, their crosstalk 
to biochemical signaling pathways such as BMP and TGF-β and YAP/TAZ 
acts on different levels, which allows now to think about new and more speci-
fied intervention strategies for age-related bone loss.
Dr. M. Reichenbach, P.-L. Mendez, C. da Silva Madaleno, V. Ugorets, 
Dr. P. Rikeit, Dr. J. Jatzlau, Prof. P. Knaus
Institute of Chemistry/Biochemistry
Freie Universität Berlin
Thielallee 63, Berlin 14195, Germany
E-mail: petra.knaus@fu-berlin.de
C. da Silva Madaleno, Dr. P. Rikeit, Dr. J. Jatzlau
Berlin-Brandenburg School for Regenerative Therapies (BSRT)
Charité—Universitätsmedizin Berlin
Föhrer Str. 15, Berlin 13353, Germany
P.-L. Mendez
International Max Planck Research School for Biology and Computation
Max Planck Institute for Molecular Genetics
Ihnestr. 63, Berlin 14195, Germany
Dr. S. Boerno
Sequencing Core Facility
Max Planck Institute for Molecular Genetics
Ihnestr. 63, Berlin 14195, Germany
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/adbi.202000051.
© 2021 The Authors. Advanced Biology published by Wiley-VCH GmbH.  
This is an open access article under the terms of the Creative Commons 
Attribution-NonCommercial-NoDerivs License, which permits use and dis-
tribution in any medium, provided the original work is properly cited, the 
use is non-commercial and no modifications or adaptations are made.
Adv. Biology 2021, 5, 2000051
www.advancedsciencenews.com www.advanced-bio.com
2000051 (2 of 15) © 2021 The Authors. Advanced Biology published by Wiley-VCH GmbH
doses,[16,17] and side effects from excess concentrations of these 
growth factors have been reported.[18] Current research strate-
gies focus on regulatory mechanisms and crosstalks to other 
pathways to collectively enhance cellular responses to physi-
ological BMP concentrations and to improve the efficacy of 
regenerative therapies for bone diseases. Of particular interest 
is the crosstalk with mechanosensitive signaling pathways, as 
it was shown that mechanical stimuli integrate into the BMP 
signaling cascade.[19–21] In an in vivo rat osteotomy model, 
mechanical loading enhanced the efficacy of BMP-2 application 
on fracture healing.[22] Likewise, Kopf et  al. used a 3D biore-
actor system to show that BMP-2 stimulation and concurrent 
mechanical loading lead to increased intensity and duration of 
SMAD1/5/8 phosphorylation, as well as increased ID transcrip-
tion in hFOBs.[19]
Actin fibers transmit, generate, and are subjected to 
mechanical forces and have been shown to act as tension sen-
sors, modulating their affinity for binding partners depending 
on the filament stress load.[23,24] Furthermore, recent work has 
shown that an intact actin cytoskeleton is crucial for osteo-
genic differentiation of MSCs.[25,26] Many actin binding pro-
teins were identified as crucial components in signal trans-
duction pathways such as the Hippo cascade.[27–29] The Hippo 
pathway with its nuclear effectors Yes-associated protein 
(YAP, gene name YAP1) and transcriptional coactivator with 
PDZ-binding motif (TAZ, gene name WWTR1) has recently 
been appreciated as a major mechanosensitive signaling cas-
cade,[30] Originally found to be regulated by cell density,[31] it 
was later discovered that cell geometry and cell spreading, 
substrate stiffness and rigidity,[32] fluid flow,[33] and cytoskel-
etal tension[27] govern Hippo-YAP/TAZ activity. Generally, in 
cells that are spread over a large area, grow on stiff substrates, 
or generate intracellular tension, YAP/TAZ translocate in the 
nucleus, where they act as transcriptional coactivators or core-
pressors together with other transcription factors, guiding 
the expression of genes involved in cell cycle control, apop-
tosis, differentiation, and migration.[34–38] YAP/TAZ activity is 
canonically regulated by LATS protein kinase, which is acti-
vated by phosphorylation in response to various inputs.[31] 
Activated LATS phosphorylates YAP/TAZ, which leads to 
their retention in the cytoplasm and therefore inactivation.[39] 
Interestingly, actin stress fibers impact Hippo signaling at the 
level of LATS or upstream, as disruption of F-actin leads to 
activation of LATS and therefore inactivation of YAP/TAZ.[40] 
The majority of YAP/TAZ effects are mediated via interaction 
with TEAD family transcription factors;[41] however, other part-
ners such as p73,[42] KLF5,[43] ERBB4,[44] or RUNX2[45] have also 
been identified. Of note, YAP and TAZ also influence SMAD-
mediated transcriptional activity.[46–49] By direct binding of 
YAP to SMADs, BMP-induced SMAD transcriptional activity 
is enhanced as it was shown during neuronal differentia-
tion of mouse embryonic stem cells (mESCs).[46] YAP/TAZ 
also interact with TGF-b regulated SMAD2/3 in a cell-den-
sity-dependent manner, dictating their subcellular localiza-
tion.[48,49] YAP/TAZ regulate expression of extracellular matrix 
proteins (e.g., COL1A1), and thereby play an important role in 
tissue regeneration and remodeling.[50–52] In bone, extracel-
lular matrix proteins provide a scaffold for the deposition of 
calcified minerals, thereby generating macroscale mechanical 
stability and flexibility.[53,54] The major scaffold here is collagen 
type  I (COL1A1 and COL1A2), whereas osteopontin (SPP1) 
and osteocalcin (OCN) contribute to the nanoscale mechanical 
behavior.[53,55–57] Matrix metalloproteases like MMP2 and MT1-
MMP degrade extracellular matrix (ECM) to direct MSC—
osteoblast commitment and differentiation via activation of 
YAP/TAZ.[58] Thus, this complex ECM network itself instructs 
osteogenesis.
In this study, we demonstrate that osteogenic differentiation 
of human osteoblasts is promoted by mechanical inputs elicited 
by fluid shear stress (FSS) and mediated via YAP/TAZ and the 
expression of ECM genes. To understand the underlying mech-
anism, we analyzed the impact of YAP/TAZ on SMAD-induced 
BMP/TGF-b signaling in proliferative and differentiating bone 
precursor cells. Here, we used hFOBs as a model cell line, as 
they were shown to integrate mechanical stimuli into the BMP 
signaling cascade and respond similar as MSCs.[19,59,60] We per-
formed a comparative whole-genome expression profiling using 
RNA sequencing (RNA-Seq) of hFOBs, depleted for YAP/TAZ 
and stimulated with BMP-2. Based on these data, we propose 
that YAP/TAZ influences both SMAD1/5 and SMAD2/3 phos-
phorylation and subsequent BMP/TGF-b-SMAD-dependent 
gene transcription through different mechanisms including 
SMAD degradation, dephosphorylation, and distinct transcrip-
tional complex formation.
2. Results
2.1. FSS Promotes Osteogenic Differentiation with Differential 
YAP/TAZ Impact
The osteoblastic niche harbors osteoblasts in the bone marrow, 
which line the endosteal bone. Mechanical inputs result in FSS 
in the intramedullary space inducing mechanotransduction 
pathways (Figure 1a).[61] To test whether FSS impinges on osteo-
genic differentiation via actin remodeling and subsequent YAP/
TAZ activation, we first subjected hFOBs to 5  dyn  cm–2 FSS 
in vitro for 1 h and analyzed their actin cytoskeleton organiza-
tion (Figure 1b). We show that FSS increased perinuclear actin 
fiber intensity already after 1  h (Figure  1b). Further, FSS pro-
moted LATS1 phosphorylation (Figure  1c) thereby indicating 
inhibition of YAP/TAZ’s transcriptional activity. This was con-
firmed by analyzing the expression of CYR61, a YAP/TAZ target 
gene (Figure  1d). Next, we induced osteogenic differentiation 
of hFOB cells via a temperature shift from 33.5 to 39.5  °C.[62] 
Actin fibers rearranged and aligned 3 days after induction of 
osteogenesis, which was quantified by measuring their orien-
tation towards a given axis using fast Fourier transformation 
(FFT) (Figure 2a).[63] Interestingly, under those osteogenic dif-
ferentiation conditions, FSS increased CYR61 gene expression, 
indicating an increase in YAP/TAZ activity (Figure  2b). Fur-
thermore, simultaneous differentiation and FSS stimulation 
enhanced expression of osteogenic matrix genes COL1A1 and 
SPP1, whereas FSS had no impact on ALP (Figure  2c). ALP 
was only induced by differentiation conditions and not further 
supported by FSS. This suggests that FSS promotes osteogenic 
differentiation through the regulation of FSS-sensitive genes, 
such as COL1A1 and SPP1, highlighting the importance of 
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mechanically induced matrix deposition in osteogenic differ-
entiation. Taken together, we show that FSS promotes actin 
remodeling and osteogenic differentiation of osteoblasts, while 
the cotranscriptional support by YAP/TAZ is dynamic and 
reduced under short term but increased upon long-term FSS 
stimulation.
2.2. FSS and YAP Regulate Genes Involved in Bone-Specific 
ECM Organization
Osteogenesis is influenced by a variety of factors including 
growth factors of the TGF-b superfamily and by mechan-
ical stimuli. Consequently, we hypothesize that the YAP/
TAZ pathway is intertwining with TGF-b and BMP signaling 
resulting in osteogenic differentiation. Thus, we performed 
a comprehensive RNA-Seq study including both YAP/TAZ 
depletion by siRNA and BMP stimulation conditions. Here, 
we determined 1381 differentially expressed genes, from which 
1331 genes (red frame) (Figure 3a) are exclusively regulated by 
YAP/TAZ, 15 genes exclusively after 1 h BMP-2 stimulation, and 
35 genes in both conditions (Venn diagram, Figure  3a). The 
1331 genes exclusively regulated upon YAP/TAZ depletion were 
subjected to hierarchical cluster analysis. The majority of genes 
(cluster  A; 911 genes) are upregulated in the absence of YAP/
TAZ, indicating that they are repressed by YAP/TAZ. Among 
those are for example, genes encoding ECM and ECM remod-
eling proteins, such as SPP1, COL3A1, MMP14, and MMP16. In 
contrast, 420 genes (cluster B) are positively regulated by YAP/
TAZ, including CYR61, CTGF, and ALP. Further, genes asso-
ciated with “osteoblast differentiation” were found deregulated 
in the absence of YAP/TAZ, highlighting an involvement of 
Figure 1. FSS enhances stress fiber formation and induces LATS phosphorylation resulting in decreased YAP-dependent target gene expression. 
a) Mechanical loading of the bone results in unidirectional FSS in the bone marrow exciting osteoblasts, which line the endosteal bone. Schematic 
drawing of the flow chamber cultivated with cells, which is used to apply FSS on an hFOB cell line. b) Actin fibers were stained using phalloidin and 
nuclei were stained using DAPI (blue). Scale bars = 20 µm. c) Representative western blot analysis and densitometric analysis of three independent 
experiments of pLATS in hFOBs pretreated with 5 dyn cm–2 FSS for 4 h. d) qPCR analysis of YAP target gene expression CYR61 in hFOBs pretreated 
with 5 dyn cm–2 FSS for 1 h. e) Graphical illustration depicting the impact of 1 h FSS on YAP activity and actin cytoskeleton.
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YAP/TAZ in this biological process (Figure  3b). Further, func-
tional enrichment of biological processes using DAVID Bioin-
formatics Resources 6.8[64] identified “ECM organization” and 
“TGF-b/BMP signaling” as overrepresented biological processes 
regulated by YAP/TAZ. In detail, genes encoding for integ-
rins, collagens, and laminins that belong to the biological pro-
cess “ECM organization” were mainly upregulated upon YAP/
TAZ depletion (Figure 3b, cluster A). Moreover, we found that 
the BMP/TGF-b signaling pathway genes (Figure  3b) encode 
ligands and ligand-binding proteins such as GDF5, GDF15, 
TGFB2, TGFB3, LTBP1, and LTBP3, the BMP coreceptor RGMB 
and BMP inhibitor BMPER, indicating a crosstalk of YAP/TAZ 
with the BMP/TGF-b pathway on multiple levels.
Therefore, we next asked how BMP2 stimulation intertwines 
with the FSS- and/or YAP-dependent target gene regulation. For 
instance, CYR61, SPP1, and COL1A1 are all relevant for osteo-
genic differentiation but members of different gene clusters 
and regulated individually by these stimuli. While all three are 
upregulated by FSS, the impact of BMP2 and/or YAP on these 
genes is different and might explain their individual functional 
Figure 2. FSS promotes osteogenic differentiation and YAP/TAZ target gene expression, whereby the actin cytoskeleton reorients during osteogenic 
differentiation. a,b) Densely plated hFOBs were starved in medium containing 2% FCS for 3 h (d0) and then cultured at proliferating (d3, 34 °C) or 
at differentiating (d3, 39.5 °C) conditions for 72 h under static conditions or 5 dyn cm–2 FSS as indicated. a) Cells were fixed and stained for actin 
cytoskeleton using phalloidin and nuclei using DAPI. Angle orientation was quantified using fast Fourier transformation (FFT) to depict alignment 
of the actin cytoskeleton. b) qPCR analysis of CYR61 mRNA. c) qPCR analysis of COL1A1, SPP1, and ALP mRNA. Data are presented as mean ± SEM 
of three independent experiments, two-way ANOVA with Bonferroni post hoc test, compared to corresponding static control samples. d) Schematic 
drawing illustrating the influence of 3D FSS on YAP and osteogenic differentiation.
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Figure 3. YAP-dependent target genes are influenced by FSS. a) Venn diagram of RNA-Seq data presenting the number of differentially expressed genes in 
hFOBs transfected with control siRNA and YAP/TAZ targeting siRNA (siY/T) for 48 h and afterwards stimulated with BMP-2 for 1 h. b) Hierarchical clustering 
of differentially expressed genes from RNA-Seq experiment (p-value < 0.05; –0.6 ≤ log2FC ≥ 0.6) of hFOBs transfected with control siRNA and YAP/TAZ 
targeting siRNA for 48 h and then stimulated with BMP-2. Clustering depicts genes differentially expressed in response to YAP/TAZ exclusively. Genes high-
lighted next to the map were revealed by functional enrichment analysis using DAVID Bioinformatics Resources 6.8.[64] c) hFOBs were starved in medium 
containing 2% FCS for 3 h, and then stimulated with 5 × 10−9 m BMP-2 and cultured under static conditions or 5 dyn cm–2 FSS differentiating (39.5 °C) 
conditions for 72 h. qPCR analysis of target mRNA identified by RNA-Seq (clusters A and B). d) hFOBs depleted for YAP and control cells were starved in 
medium containing 2% FCS for 3 h, and then stimulated with 5 × 10−9 m BMP-2 and cultured under static and differentiating (39.5 °C) conditions for 72 h. 
qPCR analysis of target mRNA identified by RNA-Seq (clusters A and B). Data are normalized to untreated control at proliferation conditions and presented 
as mean ± SEM of three independent experiments. e) FSS stimulates osteogenic BMP-2 and YAP/TAZ targets and targets shared by both pathways.
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contribution in osteogenic differentiation. CYR61 (cluster B; 
Figure  3b) is positively regulated by FSS and BMP-2 stimula-
tion as well as YAP (Figure  3c), as confirmed by depletion of 
YAP (Figure 3d) and RNA-Seq analyses (Figure 3b; Figure S2c, 
Supporting Information). SPP1 is upregulated by FSS but not 
by BMP-2 (Figure 3c), while YAP represses SPP1 under differ-
entiation conditions (Figure  3d). COL1A1 encodes the major 
osteogenic matrix protein and is cooperatively increased by 
FSS and BMP-2 stimulation (Figure  3c) and is independent 
of YAP (Figure 3b,d). This suggests that while all three genes 
are upregulated by FSS, there exists a clear separation of those 
genes, which are BMP-sensitive (e.g., COL1A1), those which 
are YAP/TAZ-sensitive (e.g., SPP1) and those, which are both 
(CYR61); (Figure 3e). We conclude that YAP/TAZ has a distinct 
impact on bone matrix formation, which only in part overlaps 
with BMP2-signaling and that FSS has the potential to override 
these regulations to some extent. Furthermore, FSS and BMP-2 
induce a bone specific matrix under differentiating conditions 
independent of YAP/TAZ signaling.
2.3. Classification of YAP/TAZ and/or SMAD1/5 Target Genes
BMP-activated SMADs have been previously shown to interact 
with YAP/TAZ to regulate target gene transcription.[46] Based 
on this, we hypothesized that SMAD1 and YAP/TAZ form a 
transcriptional complex in hFOBs. By using a proximity liga-
tion assays (PLA), we demonstrated that SMAD1 and YAP/
TAZ interact both in the cytosol and in the nucleus (Figure 4a). 
Interestingly, nuclear complexes of SMAD1 and YAP/TAZ were 
significantly enriched after BMP-2 stimulation (Figure  4a,b), 
suggesting a nuclear accumulation of transcription factor com-
plexes composed of both proteins. On the other hand, treat-
ment with the actin-disrupting agent cytochalasin D (CytoD) 
prevented the BMP-induced increase of nuclear SMAD1-YAP/
TAZ interactions (Figure 4a,b), due to a retention of YAP/TAZ 
in the cytoplasm (Figure S3c, Supporting Information) (CytoD, 
latrunculin B (LatB)). With this, we conclude that SMAD1 might 
form a transcriptional complex with YAP/TAZ that is distinct 
from the classical pSMAD1-SMAD4 complexes, to regulate gene 
expression cooperatively. Within the 50 BMP target genes identi-
fied by RNA-Seq, 35 were also regulated by YAP/TAZ (Figure 4c) 
(red frame). Interestingly, 28.5% of these genes belong to the 
Gene Ontology (GO) cluster “osteoblast differentiation” and 
include, for example, NOG, JUNB, and GADD45B (Figure 4d). 
In a hierarchical cluster analysis of all 50 identified BMP target 
genes, the YAP/TAZ-dependent BMP target genes were sub-
grouped into clusters C, E, and F (Figure  4d). Clusters C and 
E represent BMP-induced genes, which are repressed by YAP/
TAZ depletion. Cluster C comprises four BMP targets, which 
loose BMP responsiveness in the absence of YAP/TAZ, i.e., they 
are highly YAP/TAZ dependent. Interestingly, NOG encoding 
the BMP antagonist noggin is one of those four genes. Cluster 
E (six genes) includes BMP target genes, which are rather 
less affected by loss of YAP/TAZ. Among those targets is, for 
example, the growth arrest and DNA damage inducible beta 
(GADD45B), which was previously reported to regulate osteo-
genic differentiation.[65,66] Cluster D represents 15 BMP target 
genes, which are not affected by loss of YAP/TAZ (Figure  4d). 
Here, we found, for example, the ID genes (ID1–3), suggesting 
that these are not directly influenced by the mechanotransducer 
YAP/TAZ. Cluster F encompasses 25 genes that are upregu-
lated by both BMP-2 and loss of YAP/TAZ. These genes include 
junB (JUNB) and early growth response 2 (EGR2) encoding 
the mechanoresponsive transcription factors and EGR2 (Figure 
S4, Supporting Information). As these genes are repressed by 
YAP/TAZ, we consider their regulation to be independent of a 
transcriptional complex composed of SMAD1 and YAP/TAZ. 
In order to substantiate that SMAD1 directly regulates the 
target genes proposed earlier, we investigated SMAD1 binding 
loci using chromatin immunoprecipitation followed by DNA 
sequencing (ChIP-Seq) and compared it to RNA-Seq clustering 
analysis. Analysis of SMAD1 enrichment in proximity (15 kb) to 
the transcription start site (TSS) of 50 BMP regulated genes 
demonstrates that the genes classified in cluster D are strongly 
SMAD1 bound, whereas cluster C, E, and F genes show weak or 
no SMAD1 enrichment (Figure  4d). In line with this, genome 
browser view of ID1 and ID2 locus shows strong peaks around 
the TSS, whereas for, e.g., NOG, EDN1, and GADD45B, weak or 
no peaks are observed (Figure 4e; Figure S4b, Supporting Infor-
mation) around the TSS. These results recapitulate the obser-
vations from RNA-Seq, as BMP/SMAD1-induced expression of 
those genes is rather low (Figure S4a, Supporting Information).
Since genes of clusters C and E are downregulated upon 
YAP/TAZ depletion, we further predicted TEAD-binding sites 
in the respective loci in silico utilizing the cis-element finder 
CISTER (Figure S4c, Supporting Information).[69] Here, the cis-
element finder identified two TEAD cis-elements in the NOG 
locus, whereas the ID1 locus comprises no TEAD elements. 
The GADD45B locus carries one TEAD cis-element. Analysis 
of ChIP-Seq data from astrocytoma cell line[70,71] supported this 
observation, since YAP and TEAD1 show DNA occupation in 
the NOG, EDN1, and GADD45B but not in the ID1 gene. Col-
lectively, these data suggest that expression of weak SMAD1 
bound genes is enhanced by additional binding of YAP/TAZ, 
whereas some BMP target genes such as ID1–3 are inde-
pendent from YAP/TAZ-based mechanotransduction.
2.4. The Impact of Mechanical Cues and pSMAD1/5 Is Different 
on NOG as Compared to the ID Genes
The BMP-SMAD pathway has been shown to be mechanore-
sponsive at different levels of the signaling cascade.[59,72,73] Thus, 
we analyzed SMAD1/5 signaling in response to BMP-2 under 
FSS conditions at different levels of the cascade. SMAD1/5 
phosphorylation was dependent on BMP-2 and enhanced by 
FSS; however, FSS alone did not increase SMAD1/5 phospho-
rylation (Figure  5a; Figure S5a, Supporting Information). At 
this point, we asked whether this enhancement by FSS upon 
BMP-2 stimulation was mediated by YAP/TAZ: while siRNA-
mediated depletion of YAP/TAZ tends to increase both SMAD1 
total protein level and SMAD1/5 phosphorylation under static 
conditions, FSS-induced enhancement of SMAD1/5 phospho-
rylation was YAP/TAZ independent (Figure  5a). Here, we can 
exclude that this FSS-induced effect depends on endocytosis 
since inhibiting endocytosis with dynasore did not abolish 
the effect (Figure S5b, Supporting Information). Second, we 
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Figure 4. YAP/TAZ interacts with SMAD in an actin cytoskeleton-dependent manner, thereby influencing specific BMP target genes. a) PLA of Smad1 
and YAP/TAZ in hFOBs treated with 0.4 × 10−6 m CytoD or equal volume of DMSO for 1 h, followed by stimulation with 5 × 10−9 m BMP-2 for 1 h with 
quantification of nuclear ligation events. b) Quantification of PLA signals per nuclei. c) Venn diagram of RNA-Seq data presenting the number of dif-
ferentially expressed genes in hFOBs transfected with control siRNA and YAP/TAZ targeting siRNA for 48 h and afterwards stimulated with BMP-2 for 
1 h. d) On the left, hierarchical clustering of differentially expressed genes from RNA-Seq experiment (p-value < 0.05; –0.6 ≤ logFC ≥ 0.6), depicting 
differentially expressed genes upon BMP-2 stimulation. Gene Ontology revealed genes functionally related to osteoblast differentiation. Genes high-
lighted next to the map were revealed by functional enrichment analysis using DAVID Bioinformatics Resources 6.8.[64] On the right, On the right, 
heatmap depicting normalized coverage of SMAD1-binding sites from chromatin immunoprecipitation followed by sequencing experiment (–15 kb < 
TSS < 15 kb) upon BMP-2 stimulation for 90 min. Heatmap was created with deeptools using the galaxy platform.[67,68] e) Genomic loci of ID1, ID2, 
NOG, and GADD45B are shown together. The direction of transcription of the gene is indicated by the arrow beginning at the TSS.
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Figure 5. FSS enhances BMP-2-induced SMAD1/5 phosphorylation and target gene transcription, whereas YAP inhibits BMP-induced SMAD signaling. 
a) Representative western blot analysis of pSMAD1/5 in hFOBs transfected with control siRNA (scr) or siRNAs targeting YAP and TAZ (siY/T) for 48 h, pre-
treated with 5 dyn cm–2 FSS and stimulated with 5 × 10−9 m BMP-2 for 1 h under static or FSS conditions and densitometric analysis of three independent 
experiments. b) qPCR analysis of NOG and ID1 mRNA (clusters C and D) in hFOBs pretreated with 5 dyn cm–2 FSS and stimulated with 5 × 10−9 m BMP-2 
for 1 h under static or FSS conditions. c) Left: hFOBs were transfected with SMAD1-YFP and either b-galactosidase expression vector as a control (mock) 
or Flag-YAP expression vector. Representative western blot shows pSMAD1/5 and total SMAD1 level when overexpressing Flag-YAP and stimulated with 
BMP-2 for 24 h. Right: Dual luciferase assay of hFOBs transfected with BRE-Luc reporter, pRL-TK control vector, and either b-galactosidase expression 
vector as a control (mock) or Flag-YAP expression vector. Cells were starved for 6 h and then stimulated with 5 × 10−9 m BMP-2 for 24 h. Relative light 
units are presented as mean ± SD of five independent experiments. *p < 0.05, two-way ANOVA with Bonferroni post hoc test, compared to corresponding 
mock-transfected control. d) hFOBs depleted for YAP and control cells were starved in medium containing 2% FCS for 3 h, and then stimulated with 5 × 
10−9 m BMP-2 and cultured under differentiating (39.5 °C) conditions for 72 h. qPCR analysis of target mRNA NOG and ID1 identified by RNA sequencing 
(clusters C and D). Data are normalized to untreated control under proliferation conditions and presented as mean ± SEM of three independent experi-
ments. e) Schematic illustration depicting the inhibitory effect of YAP/TAZ on pSMAD1/5 and subsequent SMAD1/5-dependent target gene expression.
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analyzed transcription of selected genes (clusters C, D, and 
E) that we have identified as YAP/TAZ and BMP-dependent 
genes in response to FSS and BMP-2 stimulation, after short-
term proliferating (Figure  5b) and long-term differentiating 
conditions (Figure S5c, Supporting Information). Here, expres-
sion of NOG, ID1, ID2, and GADD45B was enhanced by FSS 
and BMP-2 stimulation in a cooperative manner, possibly 
as a consequence of enhanced SMAD1/5 phosphorylation 
(Figure  5b;  Figure  S5c,d, Supporting Information). Of note, 
induction of NOG by BMP-2 is ten times lower when compared 
to the ID genes, highlighting a requirement for high SMAD1/5 
phosphorylation levels (Figure  5b). Interestingly, both short-
term (2  h) and long-term (3  days) FSS stimulation similarly 
enhance BMP-2-induced NOG expression, even though the 
YAP activation status is different (Figures  1 and 2). This sug-
gests that FSS regulation of BMP target genes is primarily 
dependent on changes in the level of SMAD1/5-phosphoryla-
tion rather than on YAP/TAZ. Since short-term FSS-dependent 
enhancement of SMAD1/5 phosphorylation was YAP/TAZ 
independent, we checked whether long-term YAP/TAZ activa-
tion, as seen by FSS, alters SMAD1/5 phosphorylation. For this, 
we overexpressed YAP and measured both SMAD phosphoryla-
tion (Figure 5c, left) and SMAD-reporter gene activity (BRE-luc; 
Figure 5c, right; expression controls in Figure S5f, Supporting 
Information). Under both basal and BMP-2 stimulation condi-
tions, overexpression of YAP resulted in a decrease of SMAD1/5 
phosphorylation (Figure  5c, left) and reporter gene activity 
(Figure 5c, right). However, this effect was due to SMAD1 deg-
radation, as seen for both the endogenous SMAD (Figure  5c, 
right, panel 4 from bottom) and for coexpressed SMAD-YFP 
(Figure  5c, right, panel 5 from bottom), indicating a mecha-
nism independent of transcription. This suggests that YAP/
TAZ has probably multiple ways to crosstalk with BMP-SMAD 
signaling. This was most strikingly evident for NOG and ID1 
expression, when YAP/TAZ was depleted under 3D differentia-
tion conditions, whereas ID1 expression is strongly enhanced, 
induction of NOG by BMP2 is only seen when YAP/TAZ were 
depleted from cells (Figure  5d). This effect is explained by 
higher pSMAD1/5 level in the absence of YAP.
Taken together, our data identify NOG as a gene, only 
induced when high amounts of phosphorylated SMAD1/5 are 
available. This is achieved through BMP-2 plus FSS costimu-
lation, as both signals cooperatively increase the levels of 
pSMADs (Figure  5a) but also under conditions, where BMP-
2-mediated SMAD1 signaling is not disturbed by the mecha-
nosensor YAP/TAZ (Figure  5d). On the contrary, the FSS-
dependent regulation of ID1 (Figure 5b) and ID2 (Figure S5c, 
Supporting Information) is not affected by depletion of YAP/
TAZ (shown by RNA-Seq, Figure  4d), making the ID genes 
solely dependent on pSMAD1/5 (Figure 4d) but independent of 
YAP/TAZ transcriptional activity. Our data here show that FSS 
enhance BMP-2-induced pSMAD1/5 independent of YAP/TAZ 
subsequently activating BMP-dependent and cooperative target 
genes (Figure  5e). By an independent process, YAP promotes 
SMAD1 degradation, which in turn decreases the level of phos-
phorylated SMAD1/5 and its target gene transcription. This fur-
ther supports the concept that BMP-2 efficiency in osteogenic 
differentiation is largely dependent on mechanical inputs and 
crosstalk from mechanosensors, such as YAP/TAZ.
2.5. YAP/TAZ- and TGF-b-Induced SMAD2/3 Target Gene 
Expression Is Influenced by FSS and Osteogenic Differentiation
Not only BMPs influence osteogenic differentiation, but also 
TGF-b.[74] Thus, we asked whether TGF-b-SMAD2/3 signaling 
is also affected by YAP and FSS. FSS enhanced TGF-b-induced 
SMAD2 phosphorylation and subsequently TGF-b-dependent 
target gene expression (e.g., CTGF and GADD45B; Figure 6a,b). 
Apart from that, SMAD2 phosphorylation is decreased after 
3 h of TGF-b treatment in YAP/TAZ-depleted cells, whereas 
the initial SMAD2 phosphorylation is unaffected (Figure  6c). 
Next, we analyzed TGF-b target genes CTGF and GADD45B 
and osteogenic marker gene expression of ALP, SPP1, and 
COL1A1 (Figure  6d). Accordingly, all those genes are induced 
by TGF-b, whereby expression of ALP, CTGF, and GADD45B is 
clearly YAP dependent. Analyzing ChIP-Seq experiments from 
astrocytoma and breast cancer cells revealed that SMAD3 and 
YAP/TEAD occupy regulatory regions in the GADD45B and 
CTGF loci (Figure S4b, Supporting Information), suggesting 
a cotranscriptional activity of YAP and SMAD2/3. In contrast, 
YAP depletion further increases SPP1 and COL1A1 expression. 
Since COL1A1 is a YAP-independent target (Figure  3b,e), the 
observed increase is likely a consequence of YAP-dependent 
regulation of SMAD2/3 signaling rather than a YAP transcrip-
tional effect. Altogether, we conclude that FSS elevates TGF-
b-induced SMAD2/3 signaling, which cooperatively with YAP/
TAZ enhances the transcription of shared target genes.
3. Conclusion
FSS occurs in bone through the interstitial fluid flow in the 
intramedullary space and stimulates osteoblast differentia-
tion.[6,75] In order to characterize the molecular impact of FSS 
on pathway regulation and transcription in bone, we utilized an 
in vitro system allowing the application of FSS on osteoblasts. 
This enabled the detailed analysis of FSS-induced actin reor-
ganization and transcriptional and post-translational changes 
during differentiation. Here, we focused on the regulation of 
the well-characterized mechanotransducers YAP/TAZ and their 
crosstalk to the BMP-2 signaling cascade, a prominent growth 
factor signaling pathway in bone. Therefore, we performed 
RNA and ChIP-Seq to identify classes of genes distinctly reg-
ulated by YAP/TAZ and BMP-2. YAP/TAZ and SMADs share 
target genes, which play an important role in osteogenic differ-
entiation. Further, identified genes constitute specific markers 
induced upon mechanoosteogenic induction, which could be 
utilized as markers for the design of mechanical therapies of 
bone diseases like osteoporosis.
Here, we have shown that osteoblasts react to FSS by imme-
diate actin cytoskeleton remodeling to form higher-ordered 
actin bundles. At this stage, YAP/TAZ is inactivated and only 
released for activation after long-term FSS conditions. During 
osteogenic differentiation, increased YAP/TAZ target gene 
expression was described previously.[25,26] It is remarkable that 
only a subset of osteogenic marker genes is susceptible to FSS 
(e.g., SPP1 and COL1A1) while others are unaffected (e.g., ALP), 
implying a distinct contribution of mechanics into osteogenic 
differentiation control. Here, we distinguish between FSS and 
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Figure 6. FSS enhances TGF-b-induced SMAD2 signaling and target gene expression and YAP/TAZ enhances TGF-b-induced SMAD2 phosphorylation. 
a) Representative western blot analysis of pSMAD2 in hFOBs pretreated with 5 dyn cm–2 FSS and stimulated with 0.1 × 10−9 m TGF-b for 1 h under static or 
FSS conditions. b) qPCR analysis of TGF-b-dependent target gene expression of CTGF and GADD45B in hFOBs pretreated with 5 dyn cm–2 FSS and stimu-
lated with 0.1 × 10−9 TGF-b for 1 h under static or FSS conditions. c) Representative western blot analysis of hFOBs transfected with control siRNA (scr) or 
siRNAs targeting YAP and TAZ (siY/T) for 48 h, and then stimulated with 0.2 × 10−9 m TGF-b. Densitometric quantification of pSMAD2 normalized to GAPDH 
levels demonstrates a reduction in SMAD2 phosphorylation upon YAP/TAZ depletion. d) hFOBs depleted for YAP and control cells were starved in medium 
containing 2% FCS for 3 h, and then stimulated with 5 × 10−9 m BMP-2 and cultured under static conditions at proliferating (34 °C) or differentiating (39.5 °C) 
conditions for 72 h. qPCR analysis of osteogenic marker mRNA and TGF-b target gene expression. Data are presented as mean ± SEM of three independent 
experiments. e) Schematic illustration depicting the enhancing effect of YAP/TAZ on pSMAD2 and subsequent SMAD2-dependent target gene expression.
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YAP/TAZ as mechanical regulators and found that, for example, 
SPP1 expression is both sensitive to YAP/TAZ and FSS; how-
ever, FSS-mediated SPP1 is independent of YAP/TAZ. This 
implies that genes very susceptible to mechanical stimulation 
such as SPP1 are sensitive to various mechanopathways, while 
other osteogenic marker genes are differentially affected. YAP 
depletion vastly reduces transcription of the osteogenic marker 
ALP, suggesting that YAP/TAZ activity is required for osteo-
genic differentiation, which is in line with previous reports.[76–78] 
Of note, Xiong et al. observed that YAP/TAZ can have inducing 
as well as repressing effects on osteoblastic effects dependent 
on the differentiation stage in transgenic mice.[79] Here, deple-
tion of YAP/TAZ in mature osteoblasts via Dmp1-Cre inhibits 
bone formation, whereas differentiation of osteoblastic precur-
sors is promoted when YAP/TAZ is depleted via Prx1/Osx1-
Cre. In our experiments, we observe differentiation of mature 
osteoblasts with regard to matrix deposition (SPP1 and COL1A1 
expression) that coincides with these observations of YAP/TAZ 
exhibiting pro-osteogenic action at this differentiation stage.
Beside YAP/TAZ’s action as co-transcription factors, Monroe 
et al. have shown that overexpressing constitutively active YAP 
results in chromatin remodeling, thereby changing the acces-
sibility for TEAD to bind chromatin.[80] Further, YAP/TAZ 
was described to recruit the NuRD complex to DNA, which 
results in deacetylation and chromatin remodeling, conse-
quently repressing transcription.[81] Additionally, interaction 
with other chromatin remodelers including SWI/SNF complex, 
GAGA factor, and mediator complex has been reported.[82,83] 
In our RNA-Seq study, we observed that the majority of YAP/
TAZ-dependent genes (cluster A) was induced by their deple-
tion, possibly due to this chromatin remodeling effect of YAP. 
This mode of action can also be assumed for half of the shared 
BMP-YAP/TAZ target genes (cluster F; Figure 4d).
To understand the impact of FSS on osteogenic differentia-
tion, we focused on the regulation of BMP/TGF-b signaling 
by FSS-induced changes in YAP/TAZ activity, as osteogenesis 
is strongly regulated by BMP and TGF-b signaling.[84] Several 
studies on mechanosensitivity of BMP signaling show that 
mechanical inputs can be integrated into the cascade already 
at the level of BMP-receptor-mediated SMAD phosphoryla-
tion.[19,22,72] Using a 3D bioreactor system to cyclically load 
hFOBs, we previously found a cooperation between BMP-2 
stimulation and mechanical loading on SMAD activation and 
target gene transcription.[19] We confirmed this here and show 
that short-term FSS stimulation enhances BMP-induced SMAD 
signaling in hFOBs. This increase in early SMAD phosphoryla-
tion, both for SMAD1/5 and SMAD2/3, however, is clearly inde-
pendent of YAP/TAZ action, extending on the understanding of 
molecular mechanism proposed previously.
In our RNA sequencing experiment, we identified distinct 
classes of BMP target genes. NOG encoding the BMP antag-
onist noggin belongs to a class of BMP target genes highly 
dependent or susceptible to YAP/TAZ and high levels of phos-
phorylated SMAD1/5, thereby acting as a perfect sensor for 
overshooting BMP signaling, as it appears by FSS stimula-
tion or YAP/TAZ depletion. Another class includes the ID1–3 
genes, which are strongly enhanced by relatively low levels of 
phosphorylated SMAD1/5 but not altered by YAP/TAZ tran-
scriptional activity, demonstrating that IDs are high-affinity 
SMAD1/5 target genes. This promotes the concept that BMP-2 
efficiency in osteogenic differentiation is largely dependent 
on mechanical inputs and crosstalk from mechanosensors, 
such as YAP/TAZ. Based on our study, we propose four inde-
pendent modes of BMP signaling regulation by YAP/TAZ 
(Figure  7). These four modes affect either the SMAD level, 
their phosphorylation, or SMAD-induced target gene transcrip-
tion. First, YAP/TAZ as transcriptional cofactors regulate gene 
expression of BMP pathway components. In vivo knockdown 
of YAP or TAZ in mouse models was found to reduce TGF-
b1 and Smad2 expression and also Bmp4 was shown to be a 
target of YAP and TAZ.[85–87] In our study, we found primarily 
ligands, ligand-binding proteins, and the BMP coreceptor 
RGMB and the BMP inhibitor BMPER to be regulated by YAP/
TAZ. These proteins act already at the BMP receptor level and 
would result in an altered SMAD1/5 phosphorylation as seen in 
our system. Second, BMP- and TGF-b-induced transcription is 
regulated by YAP/TAZ through their interaction with SMAD1/5 
or SMAD2/3, consequently modulating gene expression of 
shared target genes (Figure  7), as shown by our RNA-Seq 
experiment. Analyzing cis-elements for SMAD1 and TEAD in 
silico[69,70,88,89] together with ChIP-Seq studies[70,71] revealed that 
YAP occupies regulatory regions proximal to the NOG, EDN1, 
and GADD45B gene locus, but SMAD1 does not or only weakly 
binds to these loci. Here, we propose that the IDs are high-
affinity target genes that are sensitive to low phospho-SMAD1 
level but their expression is not regulated by YAP/TAZ. NOG, 
EDN1, and GADD45B are low-affinity target genes, whose gene 
expression might require further transcription cofactors like 
YAP/TAZ or high levels of phospho-SMAD1/5 as triggered by 
FSS. For example, NOG is clearly dependent on both YAP/TAZ 
and SMADs being present in a transcriptional complex. Under 
conditions by which YAP/TAZ affect phospho-SMAD levels, 
this effect is difficult to judge. Short-term conditions, in which 
lack of YAP/TAZ does not affect phopho-SMAD1/5 levels (RNA-
Seq, +BMP2), show clearly that both YAP/TAZ and phospho-
SMAD1/5 are required for NOG induction. Enhanced levels 
and accumulation of pSMAD1 as seen under long-term BMP2 
stimulation (24 and 72  h) and YAP/TAZ knockdown show 
induction of NOG (Figure  5d). This clearly suggests that the 
expression level of NOG is a measure of high pSMAD1 levels 
in a cell, while other targets such as ID1 have a very different 
threshold and react already at much lower pSMAD1/5 levels. 
We also confirmed TGF-b targets, i.e., CTGF and GADD45B, 
to be YAP/TAZ dependent. Hiemer et  al. described that TGF-
b-mediated CTGF expression requires YAP/TAZ-TEAD inter-
acting with SMAD2/3 in a transcriptional complex in breast 
cancer cells.[90] Thus, the observed loss of CTGF and GADD45B 
expression upon YAP depletion could be caused by the lack of 
YAP/TEAD interaction with SMAD2/3 at respective regulatory 
regions.
Third, YAP/TAZ potentially targets SMAD1 for degradation 
in the cytosol, what might explain increased SMAD1 levels and 
SMAD-only target gene expression upon YAP/TAZ depletion 
(Figure  7). Here, it must be emphasized that this regulation 
manifests over long-term BMP2 stimulation. In contrast, stim-
ulating YAP/TAZ-depleted cells for a short time period resulted 
in a marginal increase in SMAD1/5 phosphorylation and did 
not alter SMAD-only targets like the ID genes.
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Summarizing, YAP/TAZ negatively regulate BMP signaling, 
confirming earlier reports.[91] On the other hand, it was also 
described that YAP/TAZ interact with SMAD1 at the linker 
region to prevent its proteasomal degradation.[46] In our cell 
system, we could not substantiate this, as YAP/TAZ depletion 
results in increased SMAD1 levels. Fourth, in contrast to the 
impact of YAP/TAZ on BMP signaling, YAP/TAZ depletion 
reduces TGF-b-SMAD2 phosphorylation. This occurred after 
3 h of TGF-b stimulation, while initial phosphorylation was not 
affected. As SMAD2/3 level was not altered, we assume that 
this effect is mediated by a YAP/TAZ-dependent phosphatase. 
In conclusion, we have shown that YAP/TAZ influences BMP/
TGF-b-SMAD-dependent signaling through different mecha-
nisms including SMAD degradation, dephosphorylation, and 
distinct transcriptional complex formation.
Bone homeostasis and efficient regeneration of fractures 
and defects depend on proper osteogenic differentiation of 
progenitor cells.[92] In aged patients, bone becomes brittle and 
regenerative capacity decreases, resulting in aging-associated 
diseases like osteoporosis.[93,94] The connection between FSS, 
YAP/TAZ, and BMP/TGF-b signaling crosstalk and osteogenic 
differentiation of bone progenitor cells uncovered in this study 
might, therefore, constitute a target for novel therapies treating 
age-associated bone frailty. Thereby, we recommend NOG, 
GADD45B, and CTGF as target genes, which can be monitored 
to evaluate BMP/TGF-b and mechanically induced osteogenic 
differentiation in therapeutic and screening approaches.
4. Experimental Section
Cell Culture: hFOB cells (cell line hFOB 1.10, ATCC CRL-11372) were 
cultured in a 1:1 mixture of Dulbecco’s modified Eagle’s medium (DMEM) 
and Ham’s F12 medium with 2.5 × 10−3 m l-glutamine and 8.1  mg  L–1 
phenol red (Thermo Fisher Scientific, Waltham, USA) supplemented 
with 10% fetal calf serum (FCS, Biochrom AG, Berlin, Germany) and 
antibiotics (100 U mL–1 penicillin and 0.1 mg mL–1 streptomycin, PAN-
Biotech GmbH, Aidenbach, Germany, and 0.3 mg mL–1 G418, Biochrom 
AG). The cells were grown at a permissive temperature of 33.5  °C[62] 
in a 5% CO2 humidified atmosphere for expansion and experiments 
analyzing non-differentiating cells.
Growth Factor Stimulation, Toxin Treatment, and Osteogenic 
Differentiation: Actin fibers were destabilized with CytoD (Enzo Life 
Sciences GmbH, Lörrach, Germany) and LatB (Merck KGaA, Darmstadt, 
Germany). DMSO (Carl-Roth GmbH, Karlsruhe, Germany) was used as 
a control. BMP-2 was a generous gift by Prof. W. Sebald (Biozentrum 
Universität Würzburg, Würzburg, Germany). TGF-b was obtained from 
Peprotech (Hamburg, Germany). Generally, cells were starved for 4 h 
Figure 7. Schematic illustration of the four modes shows how YAP/TAZ impacts BMP and TGF-b induced SMAD signaling.
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in media without FCS and then stimulated with 5 × 10−9 m BMP-2 or 
200 × 10−12 m TGF-b for 1 h, unless otherwise noted. For osteogenic 
differentiation, cells were starved in media containing 2% FCS for 
3 h and then cultured at either 33.5  °C as a control or at a restrictive 
temperature of 39.5  °C to induce spontaneous differentiation. Human 
FOBs were immortalized by Harris et al. using a temperature-sensitive 
mutant of the SV40 large T antigen that is active at the permissive 
temperature of 33.5  °C, leading to rapid cell division. At the restrictive 
temperature of 39.5  °C, the antigen is inactivated, proliferation stops, 
and the cells start to undergo spontaneous osteogenic differentiation.[62]
siRNA-Mediated Knockdown: To deplete YAP and TAZ, cells were 
transfected with ON-TARGETplus SMARTpool human siRNA targeting 
YAP1 or WWTR1 (L-012200-00-0005 and L-016083-00-0005, Dharmacon, 
Lafayette, USA). Cells were transfected with a final siRNA concentration 
of 50 × 10−9 m using Lipofectamine RNAiMAX (Thermo Fisher Scientific). 
Cells were analyzed 48 h post-transfection to ensure efficient knockdown.
Flow Stimulation: For shear stress experiments, hFOBs were seeded 
in flow chamber slides (ibidi GmbH, Martinsried, Germany). Static 
controls were seeded in dummy flow chambers glued on cell culture 
dishes. Cells were cultured for 48 h in these chambers, whereby medium 
was exchanged twice per day for proper nutrition supply. Laminar flow 
with a magnitude of 5  dyn  cm–2 (0.5  Pa) was applied using the ibidi 
pump system device (Figure S1, Supporting Information) (ibidi GmbH) 
assembled in the cell culture incubator. Static control samples were 
treated with the same amount of medium as flow-treated samples after 
removing dummy flow chamber.
Immunofluorescence Staining: For immunofluorescence stainings, 
cells were fixed using 4% paraformaldehyde for 10 min and were 
permeabilized in 0.1% Triton X-100 for 10 min. After blocking with 3% 
bovine serum albumin (BSA, Carl-Roth GmbH, Karlsruhe, Germany) 
in PBS for 1  h, the cells were incubated with Phalloidin CruzFluor 594 
(1:1000, Santa Cruz Biotechnology, Dallas, USA) overnight at 4  °C. 
Nuclei were counterstained with DAPI (Sigma-Aldrich, St. Louis, USA) 
for 5 min prior to microscopy at a Zeiss Axiovert 200M epifluorescence 
microscope.
In Situ PLA: For PLA, cells were plated on glass coverslips. Treated 
cells were fixed with 4% paraformaldehyde and permeabilized in 0.5% 
Triton X-100. PLA was performed using the Duolink in situ PLA technology 
(Sigma-Aldrich) according to the manufacturer’s instruction, using anti-
SMAD1 XP rabbit mAb (#6944, Cell Signaling Technology, Danvers, 
USA), anti-YAP/TAZ mouse mAb (sc-101199, Santa Cruz Biotechnology), 
and anti-SMAD4 mouse mAb (sc-7966, Santa Cruz Biotechnology) at a 
1:200 dilution. Slides were mounted using Fluoromount-G (Southern 
Biotech, Birmingham, USA) and imaged using a Leica TCS SP8 confocal 
microscope.
Quantitative Real-Time PCR: Cellular RNA was isolated using the 
NucleoSpin RNA isolation kit (Macherey-Nagel, Düren, Germany) 
according to the manufacturer’s instructions. 0.5 to 1  µg total RNA 
was reversely transcribed by incubating it with random primers 
(100  pmol  µL–1, Invitrogen, Carlsbad, USA) and M-MuLV reverse 
transcriptase enzyme (200  000 U  mL–1, New England Biolabs, 
Ispwich, USA) were added per sample. RT-PCR was performed using 
a StepOnePlus Real-Time PCR System (Thermo Fisher Scientific) with 
specific primers for the genes listed in Table S1, Supporting Information. 
Reactions were performed in triplicates in MicroAmp Optical 96-well 
reaction plates (Thermo Fisher Scientific) using SYBR Green PCR Master 
Mix (Invitrogen) or Luna PCR Master Mix (New England Biolabs). Fold 
induction was calculated by comparing relative gene expression to the 
housekeeping gene RSP9 using the ∆∆CT method.
RNA-Seq Experiment: For each experimental condition, three 
biological replicates were analyzed. After initial quality control using 
Agilent’s Bioanalyzer, sequencing libraries were prepared from 500  ng 
of total RNA per sample following Roche’s stranded “KAPA RNA 
HyperPrep” library preparation protocol for single indexed Illumina 
libraries: First, the polyA-RNA fraction was enriched using oligo-dT-
probed paramagnetic beads. Enriched RNA was heat-fragmented 
and subjected to first strand synthesis using random priming. The 
second strand was synthesized incorporating dUTP instead of dTTP to 
preserve strand information. Afterwards, A-tailing Illumina sequencing 
compatible adapters were ligated. Following bead-based clean-up steps, 
the libraries were amplified using ten cycles of PCR. Library quality and 
size was checked with qBit, Agilent Bioanalyzer and qPCR. Sequencing 
was carried out on an Illumina HiSeq 4000 system in PE75bp mode 
yielding between 15 and 23 million fragments per sample.
RNA-Seq Data Analysis: Following base calling, data were mapped 
against the GRCh38 genome obtained from http://emea.support.
illumina.com/sequencing/sequencing_software/igenome.html using 
STAR v2.5.3a (STAR: ultrafast universal RNA-Seq aligner). To find 
differentially expressed genes, a TMM normalization of the read count 
data was applied and the resulting cpm values were used for GLM-based 
testing with edgeR.[95] Genes with a logarithmic fold change smaller than 
–0.6≤ and bigger than ≥0.6 and p-value < 0.05 (genes with cpm < 3 were 
excluded) were considered to be significantly differentially expressed. For 
heatmaps, z-score of these genes was used and hierarchically clustered 
using RStudio. Clusters were identified by visual inspection. Functional 
enrichment and clustering was performed using DAVID Bioinformatics 
Resources 6.8.[64] Functional clusters with Bonferroni corrected p-value ≤ 
0.05 were considered as significant.
Chromatin Immunoprecipitation Followed by Next-Generation 
Sequencing (ChIP-Seq): For chromatin immunoprecipitation followed by 
next-generation sequencing (ChIP-Seq), cells were grown to confluence 
and then starved in 0% FCS for 3 h and stimulated with BMP-2 (5 × 
10−9 m) for 90 min. Cells were fixed in 1% formaldehyde and quenched 
by adding glycine 125 × 10−3 m for 5 min at 4 °C. After this, cells were 
harvested and lysed according to the protocol described by Lee 
et  al.[96] and chromatin was sheared by sonication using the Bioruptor 
ultrasonicator (Diagenode). Sheared chromatin was immunoprecipitated 
using 10  µg of total SMAD1 antibody (Cell Signaling, #9743) or the 
normal rabbit IgG antibody (Cell Signaling, #2729) as a control, followed 
by incubation with protein G magnetic beads (Invitrogen). DNA was 
eluted in elution buffer[96] and DNA purification was performed by 
using DNA purification buffers and spin columns kit, according to the 
manufacturer’s instructions (Cell Signaling).
Sequencing data quality was assessed prior to processing using 
FastQC (version 0.11.8). Quality trimming and adapter clipping was 
performed using cutadapt (v.2.4) with the following parameters: 
minimum length = 25, minimum quality = 20, overlap = 5, followed 
by a quality assessment using FastQC. Trimmed reads of enriched 
and input samples were aligned to GRCh38 using BWA-MEM and 
sorted using SAMtools v.1.10. BAMStats were used to monitor the 
alignment statistics. Duplicate reads were removed using GATK4/
Picard MarkDuplicates (v.4.1.4.1). Reads with a mapping quality of below 
15 were filtered using SAMtools view. Genome-wide bigWig coverage 
files were created using bamCoverage 3.4.3 without data normalization 
and with CPM normalization for enriched and input samples. Peak 
calling was performed using macs 2.1 for broad and narrow peaks on 
the enriched and corresponding input samples as control. Background 
was subtracted using macs2 bdgcmp. After completion of all steps, 
multiQC was applied to gather and compare all quality control results. 
RNA-Seq and ChIP data are published on gene expression omnibus with 
accession number GSE137035.
Western Blot: Cells were lysed in Laemmli buffer[97] and boiled at 95 °C 
for 5 min prior to separation on 10–12.5% SDS–PAGE gels. Proteins were 
transferred onto nitrocellulose membranes (neoLab Migge Laborbedarf-
Vertriebs GmbH, Heidelberg, Germany). Membranes were blocked in 
5% w/v BSA (Sigma-Aldrich) in TBST and then incubated with primary 
antibodies diluted 1:1000 overnight at 4  °C. The next day, membranes 
were incubated with goat-α-rabbit-HRP or goat-α-mouse-HRP secondary 
antibodies (1:10  000, Dianova, Hamburg, Germany), prior to detection 
with WesternBright Quantum ECL HRP substrate (advansta, Menlo 
Park, USA) using a Fusion-FX7 (Vilber Lourmat, Eberhardzell, Germany). 
Primary antibodies used were anti-GAPDH rabbit mAb (#2118, Cell 
Signaling Technology), anti-phospho-SMAD1/5 (Ser463/465) rabbit mAb 
(#9516, Cell Signaling Technology), anti-SMAD1 XP rabbit mAb (#6944, 
Cell Signaling Technology), anti-phospho-LATS1 (Thr1079) rabbit mAb 
(#8654, Cell Signaling Technology), anti-phospho-Smad2 (Ser465/467) 
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rabbit mAb (#3108 Cell Signaling Technology), anti-SMAD2 rabbit mAb 
(#3122, Cell Signaling Technology), and anti-YAP/TAZ mouse mAb 
(sc-101199, clone 63.7, Santa Cruz Biotechnology). Western blots are 
representative of at least three individual repetitions.
Dual Luciferase Assay: The cells were transfected with BMP-responsive 
element firefly luciferase reporter plasmid (BRE-Luc[98]), constitutively 
expressed Renilla luciferase plasmid (RLTK, Promega, Madison, USA), 
and Flag-YAP expression plasmid or b-galactosidase expression plasmid 
as control using Lipofectamine 2000 (Thermo Fisher Scientific). The next 
day, cells were starved for 3 h in media containing 0.5% FCS and then 
stimulated with 5 × 10−9 m BMP for 24 h. Cells were lysed in passive 
lysis buffer (Promega) and firefly and Renilla luciferase activities were 
measured using an Infinite 200 PRO plate reader (Tecan, Männedorf, 
Switzerland) according to the Dual-Luciferase reporter assay system 
protocol (Promega). Relative light units for each condition were 
calculated by normalizing firefly luciferase activity to Renilla luciferase 
activity. To confirm expression of YAP-Flag, lysate of each well from the 
triplicates was pooled and analyzed by SDS–PAGE and western blotting.
Statistics: All experiments were performed at least three times. 
Two-way analysis of variance (ANOVA) with Bonferroni post hoc test 
was performed for comparisons of multiple groups. A p-value lower than 
0.05 was considered statistically significant.
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